Cyclodextrin-Based Nanomaterials in Pharmaceutical Field

Pharmaceutical Manufacturing Handbook: Production and Processes

Volumn , Issue , 2007, Pages 1223-1247

  Bilensoy, Erem ^a   Hincal, A Attila ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Anionic amphiphilic cyclodextrins; Cyclodextrin based nanomaterials; Nanocapsule cytotoxicity

Indexed keywords

EID: 84889826194     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470259818.ch31     Document Type: Chapter

References (90)

1. Albers, E., and Müller, B. W. (1995), Cyclodextrin derivatives in pharmaceuticals, CRC Crit. Rev. Ther. Drug Carrier Syst., 12 (4), 311.
2. Loftsson, T., and Duchene, D. (2007), Cyclodextrins and their pharmaceutical applications, Int. J. Pharm., 329 (1-2), 1-11.
3. Uekama, K. (2004), Design and evaluation of cyclodextrin-based drug formulation, Chem. Pharm. Bull., 52 (8), 900-915.
4. Wenz, G. (1991), Synthesis and characterization of some lipophilic per(2,6-di-O-alkyl) cyclomaltooligosaccharides, Carbohydr. Res., 214, 257-265.
5. Duchene, D., and Wouessidjewe, D. (1992), Industrial uses of cyclodextrins and their derivatives, J. Coord. Chem., 27, 223-236.
6. Thompson, D. O. (1997), Cyclodextrins as enabling excipients: Their present and future use in pharmaceuticals, CRC Crit. Rev. Ther. Drug Carrier Syst., 14 (1), 1-110.
7. Rajewski, R. A., and Stella, V. J. (1996), Pharmaceutical applications of cyclodextrins 2. In vivo drug delivery, J. Pharm. Sci., 85 (11), 1142-1169.
8. Loftsson, T., and Brewster, M. E. (1996), Pharmaceutical applications of cyclodextrins I. Drug solubilization and stabilization, J. Pharm. Sci., 85 (10), 1017-1025.
9. Frank, D. W., Gray, J. E., and Weaver, R. N. (1976), Cyclodextrin nephrosis in the rat, Am. J. Pathol., 83, 367-382.
10. Szejtli, J., Cserhati, T., and Szögyi, M. (1986), Interactions between cyclodextrins and cell- membrane phospholipids, Carbohydr. Polym., 6, 35-49.
11. Debouzy, J. C., Fauvelle, F., Crouzy, S., Girault, L., Chapron, Y., Göschl, M., and Gadelle, A. (1997), Mechanism of α-cyclodextrin induced hemolysis 2. A study of the factors controlling the association with serine-, ethanolamine-and choline-phospholipids, J. Pharm. Sci., 87 (1), 59-66.
12. Uekama, K., Hirayama, F., and Irie, T. (1991), Modification of drug release by cyclodextrin derivatives, in Duchene, D., Ed., New Trends in Cyclodextrins and Derivatives, Editions de Santé, Paris, pp. 409-446.
13. Stella, V. J., and Rajewski, R. A. (1997), Cyclodextrins: Their future in drug formulation and delivery, Pharm. Res., 14 (5), 556-567.
14. Müller, B. W., and Brauns, U. (1986), Hydroxypropyl-β-cyclodextrin derivatives: Influence of average degree of substitution on complexing ability and surface activity, J. Pharm. Sci., 75, 571-572.
15. Yoshida, A., Yamamoto, M., Irie, T., Hirayama, F., and Uekama, K. (1989), Some pharmaceutical properties of 3-hydroxypropyl/and 2,3-dihydroxypropyl β-cyclodextrins and their solubilizing and stabilizing ability, Chem. Pharm. Bull., 37, 1059-1063.
16. Müller, B. W. (2000), Hydroxypropyl β-cyclodextrin in drug formulation, paper presented at the CRS Workshop What's New in Cyclodextrin Delivery? Paris, July 7-8, Article 3.
17. Zia, V., Rajewski, R., Bornancini, E. R., Luna, E. A., and Stella, V. J. (1997), Effect of alkyl chain length and substitution degree on the complexation of sulfoalkyl ether β-cyclodextrins with steroids, J. Pharm. Sci., 86, 220-224.
18. Stella, V. J. (2000), SBE 7M-β-CD or Captisol ®-possible utilizations, paper presented at the CRS Workshop What's New in Cyclodextrin Delivery? Paris, July 7-8, Article 4.
19. Ma, D. Q., Rajewski, R. A., and Stella, V. J. (1999), Thermal properties and processing of (sulfobutylether)-7M-β-cyclodextrin as a freeze-drying excipient in pharmaceutical formulations, STP Pharma Sci., 9 (3), 261-266.
20. Komiyama, M., Yamamoto, Y., and Hirai, H. (1984), Complex formation of modified cyclodextrins with organic salts in organic solvents, Chem. Lett., 1081-1084.
21. Uekama, K., Horiuchi, Y., İrie, T., and Hirayama, F. (1989), O-Carboxymethyl-O-ethyl- cyclomaltoheptaose as a delayed-release type drug carrier. Improvement of the oral availability of diltiazem, Carbohydr. Res., 192, 323-330.
22. Uekama, K., Hirayama, F., and Irie, T. (1998), Cyclodextrin drug carrier systems, Chem. Rev., 98, 2045-2076.
23. Anand, R., Nayyar, S., Pitha, J., and Merril, C. R. (1990), Sulphated sugar alpha- cyclodextrin sulphate, a uniquely potent anti-HIV agent, also exhibits marked synergism with AZT, and lymphoproliferative activity, Antiviral Chem. Chemother., 1, 41-46.
24. Friedman, R. (1991), Cyclodextrin-containing polymers, in Duchene, D., Ed., New Trends in Cyclodextrins and Polymers, Editions de Santé, Paris, pp. 157-178.
25. Sebillé, B. (1987), Cyclodextrin derivatives, in Duchene, D., Ed., C yclodextrins and Their Industrial Uses, Editions de Santé, Paris, pp. 351-393.
26. Memişoǧlu, E., Bochot, A., Şen, M., Duchene, D., and Hincal, A. A. (2003), Non-surfactant nanospheres of progesterone inclusion complexes with amphiphilic ß-cyclodextrins, Int. J. Pharm., 251, 143-153.
27. Monza de Silveira, A., Ponchel, G., Puisieux, F., and Duchene, D. (1998), Combined poly (isobutylcyanoacrylate) and cyclodextrin nanoparticles for enhancing the encapsulation of lipophilic drug, Pharm. Res., 15 (7), 1051-1055.
28. Duchene, D., Ponchel, G., and Wouessidjewe, D. (1999), Cyclodextrins in targeting. Application to nanoparticles, Adv. Drug Deliv. Rev., 36, 29-40.
29. Boudad, H., Legrand, P., LeBas, G., Cheron, M., Duchene D., and Ponchel, G. (2001), Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir, Int. J. Pharm., 218, 113-124.
30. Challa, R., Ahuja, A., Ali, J., and Khar, R. K. (2005), Cyclodextrins in drug delivery. An updated review, AAPS PharmSciTech, 6 (2), E329-E357.
31. Cavalli, R., Peira, E., Caputo, O., and Gasco, M. R. (1999), Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with β-cyclodextrins, Int. J. Pharm., 182, 59-69.
32. Radwan, M. A. (2001), Preparation and in vivo evaluation of parenteral metoclopramide- loaded poly(alkylcyanoacrylate) nanospheres in rats, J. Microencapsul., 18, 467-477.
33. Luppi, B., Cerchiara, T., Bigucci, F., Caponio, D., and Zecchi, V. (2005), Bovine serum albumin nanospheres carrying progesterone inclusion complexes, Drug Deliv., 12, 281-287.
34. Maestrelli, F., Garcia-Fuentes, M., Mura, P., and Alonso, M. J. (2006), A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin, Eur. J. Pharm. Biopharm., 69 (2), 79-86.
35. Sajeesh, S., and Sharma, C. P. (2006), Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery, Int. J. Pharm., 325, 147-154.
36. Eguchi, M., Da, Y. Z., Ogawa, Y, Okada, T., Yumoto, N., and Kodaka, M. (2006), Effects of conditions for preparing nanoparticles composed of aminoethylcarbamoyl-β- cyclodextrin and ethylene glycol diglycidyl ether on trap efficiency of a guest molecule, Int. J. Pharm., 311, 215-222.
37. Bellocq, N. C., Pun, S. H., Jensen, G. S., and Davis, M. E. (2003), Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery, Bioconjug. Chem., 14, 1122-1132.
38. Hwang, S., Bellocq, N., and Davis, M. (2001), Effects of structure of beta-cyclodextrin- containing polymers on gene delivery, Bioconjug. Chem., 12, 280-290.
39. Hede, K. (2005), Blocking cancer with RNA interference moves toward the clinic, J. Natl. Cancer Inst., 97 (4), 626-628.
40. Gao, H., Wang, Y. N. Fan, Y. G., and Ma, J. B. (2006), Conjugates of poly(dl-lactic acid) with ethylenediamino or diethylenetriamino bridged bis(β-cyclodextrin)s and their nanoparticles as protein delivery systems, J. Controlled Release, 112, 301-311.
41. Gao, H., Wang, Y. N., Fen, Y. G., and Ma, J. B. (2007), Conjugation of poly(dl-lactide-co- glycolide) on amino cyclodextrins and their properties as protein delivery system, J. Biomed. Mater. Rest. A, 80A, 111-122.
42. Daoud-Mahammed, S., Ringard-Lefebvre, C., Razzouq, N., Rosilio, V., Gillet, B., Couvreur, P., Amiel, C., and Gref, R. (2007), Spontaneous association of hydrophobized dextran and poly-β-cyclodextrin into nanoassemblies, J. Colloid Interf. Sci., 307 (1), 83-93.
43. Wang, H., Chen, Y., Liu, X. Y., and Liu, Y. (2007), Synthesis of oligo(ethylenediamino)-β- cyclodextrin modified gold nanoparticles as a DNA concentrator, Mol. Pharm., 4 (2), 189-198
44. Park, I. K., van Recum, H. A., Jiang, S., and Pun, S. H. (2006), Supramolecular assembly of cyclodextrin-based nanoparticles on solid surfaces for gene delivery, Langmuir, 22, 8478-8484.
45. Munoz, M., Deschenaux, R., and Coleman, A. W. (1999), Observation of microscopic patterning at the air/water interface by mixtures of amphiphilic cyclodextrins - A comparison isotherm and Brewster angle microscopy study, J. Phys. Org. Chem., 12, 364-369.
46. Duchene, D., Wouessidjewe, D., and Ponchel, G. (1999), Cyclodextrins and carrier systems, J. Controlled Release, 62, 263-268.
47. Memisoglu-Bilensoy, E., Bochot, A., Trichard, L., Duchene, D., and Hincal, A. A. (2005), Amphiphilic cyclodextrins and microencapsulation, in Benita, S., Ed, Microencapsulation, 2nd rev. ed., Taylor & Francis, New York, pp. 269-295.
48. Bellanger, N., and Perly, B. (1992), NMR investigations of the conformation of new cyclodextrins -based amphiphilic transporters for hydrophobic drugs: Molecular lollipops, J. Mol. Struct., 15, 215-226.
49. Dodziuk, H., Chmurski, K., Jurczak, J., Kozminski, W., Lukin, O., Sitkowski, J., and Stefaniak, J. (2000), A dynamic NMR study of self-inclusion of a pendant group in amphiphilic 6-thiophenyl-6-deoxycyclodextrins, J Mol. Struct., 519, 33-36.
50. Lin, J. (1995), Synthése des cyclodextrins amphiphiles etétude de leur incorporation dans des phases phospholipidiques, Ph.D. dissertation, University of Paris, Paris.
51. Kawabata, Y., Matsumoto, M., Tanaka, M., Takahashi, H., Irinatsu, Y., Tagaki, W., Nakahara, H., and Fukuda, K. (1983), Formation and deposition of monolayers of amphiphilic β-cyclodextrin derivatives, Chem. Lett., 1933-1934.
52. Djedaini, F., Coleman, A. W., and Perly, B. (1990), New cyclodextrins based media for vectorization of hydrophilic drug, mixed vesicles composed of phospholipids and lipophilic cyclodextrins, in Duchene, D., Ed., Minutes of the 5th International Symposium on Cyclodextrins, Editions de Santé, Paris, pp. 328-331.
53. Liu, F. Y., Kildsig, D. O., and Mitra, A. K. (1992), Complexation of 6-acyl-O-β-cyclodextrin derivatives with steroids, effects of chain length and substitution degree, Drug Del. Ind. Pharm., 18, 1599-1612.
54. Zhang, P., Ling, C. C., Coleman, A. W., Parrot-Lopez, H., and Galons, H. (1991), Formation of amphiphilic cyclodextrins via hydrophobic esterification at the secondary hydroxyl face, Tetrahedron Lett., 32, 2769-2770.
55. Zhang, P., Parrot-Lopez, H., Tchoreloff, P., Basakin, A., Ling, C. C., De Rango, C., and Coleman, A. W. (1992), Self-organizing systems based on amphiphilic cyclodextrins diesters, J. Phys. Org. Chem., 5, 518-528.
56. Memişoǧlu, E., Charon, D., Duchene, D., and Hincal, A. A. (1999), Synthesis of per(2,3- di-O-hexanoyl)-β-cyclodextrin and characterization amphiphilic cyclodextrins nanoparticles, in Torres-Labandeira, J., and Vila-Jato, J., Eds., Proceedings of the 9th International Symposium on Cyclodextrins, Kluwer Academic, Dordrecht, pp. 622-624.
57. Lesieur, S., Charon, D., Lesieur, P., Ringerd-Lefebvre, C., Muguet, V., Duchene, D., and Wouessidjewe, D. (2000), Phase behaviour of fully-hydrated DMPC-amphiphilic cyclodextrin systems, Chem. Phys. Lip., 10, 127-144.
58. Canceill, J., Jullien, L., Lacombe, L., and Lehn, J. M. (1992), Channel type molecular structures, Part 2, synthesis of bouquet-shaped molecules based on a β-cyclodextrin core, Helv. Chim. Acta, 75, 791-812.
59. Auzely-Velty, R., Djedaini-Pilard, F., Desert, S., Perly, B., and Zemb, T. (2000), Micellization of hydrophobically modified cyclodextrins 1. Miceller structures, Langmuir, 16, 3727-3734.
60. Tchoreloff, P., Boissonnade, M. M., Coleman, A. W., and Baszkin, A. (1995), A mphiphilic monolayers of insoluble cyclodextrins at the water/air interface. Surface pressure and surface potential studies, Langmuir, 11, 191-196.
61. Ringard-Lefebvre, C., Bochot, A., Memişoǧlu, E., Charon, D., Duchene, D., and Baszkin, A. (2002), Effect of spread amphiphilic β-cyclodextrins on interfacial properties of the oil/water system, Coll. Surf. B Biointerf., 25, 109-117.
62. Memişoǧlu, E., Bochot, A., Şen, M., Charon, D., Duchene, D., and Hincal, A. A. (2002), Amphiphilic β-cyclodextrins modified on the primary face: Synthesis, characterization and evaluation of their potential as novel excipients in the preparation of nanocapsules, J. Pharm. Sci., 95 (1), 1214-1224.
63. Bilensoy, E., Doǧan, A. L., Şen, M., and Hincal, A. A. (2007), Complexation behaviour of antiestrogen drug tamoxifen citrate with natural and modified cyclodextrins, J. Inclus. Phenom. Macroc. Chem., 57, 651-655.
64. Alexandre, S., Coleman, A. W., Kasselouri, A., and Valleton, J. M. (1996), Scanning force microscopy investigation of amphiphilic cyclodextrin Langmuir-Blodgett films, Thin Solid Films, 284-285, 765-768.
65. Tanaka, M., Ishizuka, U., Matsumoto, M., Nakamura, T., Yabe, A., Nakanishi, H., Kawabata, Y., Takahashi, H., T amura, S., Tagaki, W., Nakahara, H., and Fukuda, K. (1987), Host-guest complexes of an amphiphilic β-cyclodextrin and azobenzene derivatives in Langmuir-Blodgett films, Chem. Lett., 1307-1310.
66. Mazzaglia, A., Angelini, N., Darcy, R., Donohue, R., Lombardo, D., Micali, N., Sciortino, M. T., Villari, V., and Scolaro, L. M. (2003), Novel heterotropic colloids of anionic porphyrins entangled in cationic amphiphilic cyclodextrins: Spectroscopic investigation and intracellular delivery, Chem. Eur. J., 9, 5762-5769.
67. Matsumoto, M., Matsuzawa, Y., Noguchi, S., Sakai, H., and Abe, M. (2004), Structure of Langmuir-Blodgett films of amphiphilic cyclodextrin and water-soluble benzophenone, Mol. Cryst. Liq. Cryst., 425, 197-204.
68. Cryan, S. A., Holohan, A., Donohue, R., Darcy, R., and O'Driscoll, C. M. (2004), Cell transfection with polycationic cyclodextrin vectors, Eur. J. Pharm. Sci., 21, 625-633.
69. Dubes, A., Bouchu, D., Lamartine, R., and Parrot-Lopez, H. (2001), An efficient regiospecific synthetic route to multiply substituted acyl-sulphated ß-cyclodextrins, Tetrahedron Lett., 42, 9147-9151.
70. Dubes, A., Degobert, G., Fessi, H., and Parrot-Lopez, H. (2003), Synthesis and characterisation of sulfated amphiphilic alpha-, beta-and gamma-cyclodextrins: Application to the complexation of acyclovir, Carbohydr. Res., 338, 2185-2193.
71. Granger, C. E., Feliz, C. P., Parrot-Lopez, H., and Langlois, B. R. (2000), Fluorine containing ß-cyclodextrin: A new class of amphiphilic carriers, Tetrahedron Lett., 41, 9257-9260.
72. Péroche, S., Degobert, G., Putaux, J. L., Blanchin, M. G., Fessi, H., and Parrot-Lopez, H. (2005), Synthesis and characterization of novel nanospheres made from amphiphilic perfluoroalkylthio-ß-cyclodextrins, Eur. J. Pharm. Biopharm., 60, 123-131.
73. Skiba, M., Skiba-Lahiani, M., and Arnaud, P. (2002), Design of nanocapsules based on novel fluorophilic cyclodextrin derivatives and their potential role in oxygen delivery, J. Inclus. Phenom. Macroc. Chem., 44, 151-154.
74. Fessi, H. C., Devissaguet, J. P., Puisieux, F., and Thies, C. (1997), Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles, U.S. Patent 5,118,528.
75. Wouessidjewe, D., Skiba, M., Leroy-Lechat, F., Lemos-Senna, E., Puisieux, F., and Duchene, D. (1996), A new concept in drug delivery based on "skirt-shaped cyclodextrins aggregates" present state and future prospects, STP Pharma. Sci., 6, 21-26.
76. Lemos-Senna, E., Wouessidjewe, D., Lesieur, S., Puisieux, F., Couarrazze, G., and Duchene, D. (1998), Evaluation of the hydrophobic drug loading characteristics in nanoprecipitated amphiphilic cyclodextrins nanospheres, Pharm. Dev. Technol., 3, 1-10.
77. Lemos-Senna, E., Wouessidjewe, D., Lesieur, S., and Duchene, D. (1998), Preparation of amphiphilic cyclodextrin nanospheres using the emulsion solvent evaporation method, influence of the surfactant on preparation and hydrophobic drug loading, Int. J. Pharm., 170, 119-128.
78. Lemos-Senna, E. (1998), Contribution a l'etude pharmacotechnique et physicochimique de nanospheres de cyclodextrins amphiphiles comme transporteurs de principes actifs, Ph.D. thesis, University of Paris, Paris.
79. Skiba, M., Wouessidjewe, D., Fessi, H., Devissaguet, J. P., Duchene, D., and Puisieux, F. (1992), Preparation et utilizations des nouveau systemes colloidaux dispersibles a base de cyclodextrines sous forme de nanocapsules, French Patent 92-07285.
80. Memisoglu-Bilensoy, E., Doǧan, A. L., and Hincal, A. A. (2006), Cytotoxic evaluation of injectable amphiphilic cyclodextrin nanoparticles on fibroblasts and polymorphonuclear cells: Surfactant effect, J. Pharm. Pharmacol., 58 (5), 585-589.
81. Memişoǧlu-Bilensoy, E., Şen, M., and Hincal, A. A. (2006), Effect of drug physicochemical properties on in vitro characteristics of amphiphilic cyclodextrin nanospheres and nanocapsules, J. Microencapsul., 23 (1), 59-68.
82. Memişoǧlu-Bilensoy, E., Vural, İ., Renoir, J. M., Bochot, A., Duchene, D., and Hincal, A. A. (2005), Tamoxifen citrate loaded amphiphilic β-cyclodextrin nanoparticles: In vitro characterization and cytotoxicity, J. Controlled Release, 104, 489-496.
83. Vural, İ., Memişoǧlu-Bilensoy, E., Renoir, J. M., Bochot, A., Duchene, D., and Hincal, A. A. (2005), Transcription efficiency of tamoxifen citrate loaded β-cyclodextrin nanoparticles, J. Drug Deliv. Sci. Technol., 15 (5), 339-342.
84. Bilensoy, E., Gürkaynak, O., Ertan, M., Şen, M., and Hincal, A. A., Development of non-surfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel, J. Pharm. Sci., DOI: 10.1002/jps.2111, Published online.
85. Bilensoy, E., Gürkaynak, O., Doǧan, A. L., Duman, M., and Hincal, A. A., Safety and efficacy of amphiphilic cyclodextrin nanoparticles for paclitaxel delivery, Int. J. Pharm., DOI: 10.1016/j.ijpharm.2007.06.05.
86. Çirpanli, Y., Bilensoy, E., Çaliş, S., and Hincal, A. A. (2006), Camptothecin inclusion complexes with natural and modified β-cyclodextrins, in Proceedings of the 33rd Annual Meeting and Exhibition on Controlled Release Society, Vienna, July, 22-26 pp. 988-989.
87. Çirpanli. Y., Bilensoy, E., Çaliş, S., and Hincal, A. A. (2007), Development of camptothecin loaded nanoparticles from amphiphilic β-cyclodextrin derivatives, paper presented at the Pharmaceutical Sciences World Congress PSWC, Amsterdam, April, 22-25.
88. Sortino, S., Mazzaglia, A., Scolaro, L. M., Merlo, F. M., Volveri, V., and Sciortino, M. T. (2006), Nanoparticles of cationic amphiphilic cyclodextrins entangling anionic porphyrins as carrier-sensitizer system in photodynamic cancer therapy, Biomaterials, 27, 4256-4265.
89. Skiba, M., Morvan, C., Duchene, D., and Puisieux, F., (1995), E valuation of the gastrointestinal behaviour in the rat of amphiphilic β-cyclodextrin nanocapsules loaded with indomethacin, Int. J. Pharm., 126, 275-279.
90. Memisoglu-Bilensoy, E., and Hincal, A. A. (2006), Sterile injectable cyclodextrin nanoparticles: Effects of gamma irradiation and autoclaving, Int. J. Pharm., 311, 203-208.